Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like bricks that communicate with each other within a structure. In this way, th...
Read more
The Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau have participated in a major international study that evaluated the efficacy and safety of total neoadjuvant therapy (TNT) in pat...
Read more
Researchers have identified genomic alterations associated with treatment response in HER2-positive breast cancer.
Read more
The study, published in the journal Bioorganic Chemistry, identifies molecules capable of blocking a key interaction in the progression of this type of tumor.
Read more
Human eggs are some of the most patient cells in the body, lying dormant for decades until needed. A study published today in The EMBO Journal shows that the cells deliberately slow the activity of th...
Read more
Sugieren que el NT-proBNP constituye una herramienta potente, accesible y económica para la estratificación del riesgo en pacientes con infarto agudo de miocardio con elevación del segmento ST (IAM...
Read more
New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies
Read more
The deeptech company DevsHealth, a member of Catalonia.health, and the Foundation for the Research of Neglected Diseases (FNDR), based in India, announce the identification of DHFLV_003B, the first an...
Read more
Highlight Therapeutics and CNIO are collaborating to proof BO-112 effectiveness against the most common form of skin cancer, which is linked to sun exposure and is on the rise.
Read more
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral Sclerosis (ALS) developed at the Universitat Autònoma de Barcelona and li...
Read more
This study provides the first evidence that NT-proBNP can predict disease before symptoms appear, paving the way for a new line of research already underway. The same team is now conducting a follow-u...
Read more
The study demonstrates that incorporating the HER2DX genomic test—developed by Reveal Genomics and capable of capturing both clinical and biological factors—enables better risk stratification and ...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Many repetitive regions of the genome have been considered “junk DNA...
